Odyssey Health (ODYY) Gross Margin (2014 - 2016)

Odyssey Health (ODYY) posted quarterly Gross Margin of 24.43% for Q3 2016, down 59.28% quarter-over-quarter from 60.0% in Q2 2016.

Odyssey Health (ODYY) Gross Margin (2014 - 2016) Analysis & Trends

Odyssey Health's Gross Margin history runs 3 years deep, the most recent figure standing at 24.43% for Q3 2016.

In Q3 2016, Gross Margin changed N/A year-over-year to 24.43%; the TTM figure through Apr 2017 stood at 24.43% (down 3557.0% YoY), while the FY2016 annual figure was 45.8%, up 3463.0% from the prior year.
Gross Margin for Q3 2016 stood at 24.43%, down from 60.0% in the prior quarter.
The five-year high for Gross Margin was 60.0% in Q2 2016, with the low at 10.28% in Q4 2014.
The 3-year median for Gross Margin is 12.22% (2015), against an average of 23.83%.
Peak annual rise in Gross Margin reached 4778 bps in 2016, while the deepest fall reached 4778 bps in 2016.
Odyssey Health's Gross Margin stood at 10.28% in 2014, then advanced by 19 bps to 12.22% in 2015, then jumped by 100 bps to 24.43% in 2016.
Business Quant data shows ODYY's Gross Margin at 24.43% in Q3 2016, 60.0% in Q2 2016, and 12.22% in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn	57.71%
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn	68.27%
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn	65.35%
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn	70.71%
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn	77.46%
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn	63.44%
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn	41.17%
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn	47.38%
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn	45.84%
10	Odyssey Health	1.01 Mn	711,880.61	-	-

Download Data